Anna studied Biology at the University of Patras in Greece, before completing an International master’s in Molecular Biomedicine at the National and Kapodistrian University of Athens (NKUA). For her master’s project she joined Alexander Fleming Biomedical Sciences Research Centre where she investigated the role of long-non coding RNAs in colorectal cancer.

In 2020, Anna was awarded a fellowship from the European Molecular Biology Laboratory (EMBL) and moved to the UK to pursue her PhD at EMBL-EBI and the University of Cambridge under the supervision of Prof. Irene Papatheodorou. Her doctoral research focused on developing computational pipelines for the integration of bulk transcriptomics with single-cell data, enabling large-scale deconvolution of complex tissues. She applied these approaches to cutaneous melanoma to address key biological questions about how tissue microenvironment changes during cancer progression.

Anna is now a Postdoctoral Fellow in the Haniffa Group at the Wellcome Sanger Institute. Her current research explores the molecular dynamics of skin diseases, particularly eczema, with the aim of understanding patient responses to therapy and identifying new treatment targets. She combines cutting-edge multi-omics technologies with advanced computational approaches to uncover the cellular and molecular mechanisms driving disease.